These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26559658)

  • 1. Efficacy and Safety of Citalopram in Treating Post-Stroke Depression: A Meta-Analysis.
    Tan S; Huang X; Ding L; Hong H
    Eur Neurol; 2015; 74(3-4):188-201. PubMed ID: 26559658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor: A Systematic Review and Meta-Analysis.
    Jones JS; Kimata R; Almeida OP; Hankey GJ
    Stroke; 2021 Aug; 52(9):2802-2808. PubMed ID: 34167325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis.
    Kalbouneh HM; Toubasi AA; Albustanji FH; Obaid YY; Al-Harasis LM
    J Am Heart Assoc; 2022 Jul; 11(13):e025868. PubMed ID: 35730636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of nine antidepressants in treating Chinese patients with post-stroke depression: A network meta-analysis.
    Li X; Zhang C
    J Affect Disord; 2020 Apr; 266():540-548. PubMed ID: 32056924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice.
    Kyle CJ; Petersen HE; Overø KF
    Depress Anxiety; 1998; 8(4):147-53. PubMed ID: 9871816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
    Zhang Y; Becker T; Ma Y; Koesters M
    BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson's Disease(PD) Patients.
    Qiu BY; Qiao JX; Yong J
    Iran J Pharm Res; 2014; 13(4):1213-9. PubMed ID: 25587309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
    J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram in the treatment of depression and other potential uses in psychiatry.
    Tan JY; Levin GM
    Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis.
    Zhou S; Liu S; Liu X; Zhuang W
    Medicine (Baltimore); 2020 Feb; 99(6):e19062. PubMed ID: 32028426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.